[PAFAC Study. Secondary prevention of atrial fibrillation after cardioversion].
Nitschmann
S
S
Antz
M
M
Kuck
K-H
KH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D004554:Electric Countershock / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011802:Quinidine / Q000627:therapeutic use*; D055502:Secondary Prevention; D013015:Sotalol / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome; D014700:Verapamil / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D013015:Sotalol; D014700:Verapamil; D011802:Quinidine